2312-15-4

应用筛选条件

关键词:'2312-15-4'

显示 1-2 共 2 条结果关于 "2312-15-4" 范围论文

Molecular genetics of familial hypercholesterolemia in Spain: Ten novel LDLR mutations and population analysis.

A B García-García et al.

Human mutation, 18(5), 458-459 (2001-10-23)

Mutations underlying FH in Spain are largely unknown because only a few and limited surveys have been carried out on Spanish FH patients up to now. To gain information on this issue, we have analysed a group of 113 unrelated

Pharmacokinetics of nicotinamide in cancer patients treated with accelerated radiotherapy: the experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer.

J Bernier et al.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 48(2), 123-133 (1998-10-23)

The EORTC has initiated studies to combine nicotinamide with carbogen in accelerated fractionation schedules (ARCON), since for some tumour types, acute and chronic hypoxia as well as treatment protraction may prejudice the outcome of radiotherapy. The tolerable dose of nicotinamide

1/1